Hey there. If you go down to the overview of the portfolio, we explain the reasoning:
"Growth seems to be somewhat lagging at Texas Instruments, as revenue and earnings slip and dividend growth comes in lower and lower. In hindsight, the better semiconductor play would have been Broadcom (AVGO), which we hold in the high-yield portfolio; however, at the time, we felt Texas Instruments would have been able to move the needle a bit more.
This is not to say that we view Texas Instruments as a bad company. We're shifting the capital to a company we know has a wider moat and more attractive valuations."
The company we moved the capital to was UnitedHealth